APPLICATION
ANDA202033
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-15
LATEST ACTION
2023-09-12
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 100MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 25MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 200MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
METOPROLOL SUCCINATEDiscontinued
METOPROLOL SUCCINATE EQ 50MG TARTRATE · TABLET, EXTENDED RELEASE · ORAL
Approval history
2023-09-12Labeling · Supplement 14 · standardAP
2023-04-11Labeling · Supplement 11 · standardAP
2023-04-11Labeling · Supplement 9 · standardAP
2016-06-13Labeling · Supplement 4 · standardAP
2011-12-15UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.